BlueRock Therapeutics – exPDite-2 Study for Parkinson's disease

Skip to content

Exploring a new way
About the study
Are you a good fit?
Study locations

Protected: HomeCandace Roberts2025-04-03T00:32:09+00:00

This content is password protected. To view it please enter your password below:

Password:

Bemdaneprocel is currently being studied and is not approved for use in any country.

The sponsor of the exPDite-2 study is BlueRock Therapeutics.

430 E 29th Street
New York, NY 10016

Privacy Policy
Terms of Use

MED-CA-BMPL-2400002v3 (03/25)

© Copyright 2025 | BlueRock Therapeutics | All Rights Reserved